Adoption Trend Of Biotechnology Based Diagnostic Tool

This research paper explores the evolving role of biotechnology in early cancer detection through a comparative analysis of practices in India and South Korea. Relying on secondary sources including academic papers, government reports, and verified health data, the study examines key diagnostic innovations like liquid biopsy, real-time PCR, and NGS (Next-Generation Sequencing). The research highlights how these tools are being adopted differently in both countries, shedding light on healthcare accessibility, public awareness, and technological readiness. The paper contributes to understanding how biotechnology can be used to reduce diagnostic delays and promote equity in healthcare.